Hale, Royston Join Biocept Board

Xconomy San Diego — 

San Diego-based Biocept, a cancer diagnostics and advanced laboratory services company, recently announced that David Hale has joined its board of directors as executive chairman—a move that could pave the way for Hale to eventually step in as the company’s CEO. Forward Ventures partner Ivor Royston also has joined Biocept as a director. Royston was a co-founder of Hybritech, the fount of San Diego’s startup life sciences community. Hale served as Hybritech’s president, COO, and CEO. Biocept says it plans to launch its first product, a diagnostic test for breast cancer, later this year.